CONMED Operating Margin 2010-2022 | CNMD

Current and historical operating margin for CONMED (CNMD) over the last 10 years. The current operating profit margin for CONMED as of June 30, 2022 is 10.04%.
CONMED Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2022-06-30 $1.04B $0.11B 10.56%
2022-03-31 $1.02B $0.11B 10.98%
2021-12-31 $1.01B $0.11B 10.88%
2021-09-30 $0.99B $0.10B 9.90%
2021-06-30 $0.98B $0.10B 10.21%
2021-03-31 $0.88B $0.05B 6.01%
2020-12-31 $0.86B $0.05B 5.33%
2020-09-30 $0.88B $0.05B 5.60%
2020-06-30 $0.87B $0.04B 4.71%
2020-03-31 $0.95B $0.08B 8.52%
2019-12-31 $0.96B $0.08B 8.38%
2019-09-30 $0.93B $0.08B 8.37%
2019-06-30 $0.90B $0.07B 7.67%
2019-03-31 $0.88B $0.07B 7.66%
2018-12-31 $0.86B $0.07B 8.38%
2018-09-30 $0.84B $0.07B 8.21%
2018-06-30 $0.83B $0.07B 8.45%
2018-03-31 $0.81B $0.07B 8.13%
2017-12-31 $0.80B $0.05B 5.90%
2017-09-30 $0.78B $0.04B 4.76%
2017-06-30 $0.77B $0.04B 4.92%
2017-03-31 $0.77B $0.03B 4.29%
2016-12-31 $0.76B $0.04B 5.11%
2016-09-30 $0.75B $0.04B 5.20%
2016-06-30 $0.73B $0.04B 5.45%
2016-03-31 $0.72B $0.04B 6.09%
2015-12-31 $0.72B $0.05B 7.09%
2015-09-30 $0.72B $0.06B 7.61%
2015-06-30 $0.73B $0.04B 5.76%
2015-03-31 $0.74B $0.05B 6.25%
2014-12-31 $0.74B $0.05B 7.03%
2014-09-30 $0.75B $0.05B 6.82%
2014-06-30 $0.75B $0.06B 7.71%
2014-03-31 $0.76B $0.06B 7.66%
2013-12-31 $0.76B $0.06B 7.48%
2013-09-30 $0.76B $0.06B 7.63%
2013-06-30 $0.76B $0.06B 8.26%
2013-03-31 $0.76B $0.06B 8.42%
2012-12-31 $0.77B $0.07B 8.47%
2012-09-30 $0.75B $0.01B 0.80%
2012-06-30 $0.74B $0.01B 1.08%
2012-03-31 $0.74B $0.01B 1.09%
2011-12-31 $0.73B $0.01B 1.10%
2011-09-30 $0.72B $0.06B 8.85%
2011-06-30 $0.72B $0.06B 8.73%
2011-03-31 $0.72B $0.06B 8.47%
2010-12-31 $0.71B $0.06B 8.13%
2010-09-30 $0.72B $0.06B 7.64%
2010-06-30 $0.72B $0.05B 6.22%
2010-03-31 $0.71B $0.04B 4.95%
2009-12-31 $0.70B $0.03B 4.03%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $3.073B $1.011B
CONMED Corporation is a major medical products manufacturer specializing in surgical instruments and devices for minimally invasive procedures and monitoring. A significant portion of the company's revenues are derived from products designed for the orthopedic surgery markets of arthroscopy and powered surgical instruments. The company also sells products for general and other surgical specialties such as electrosurgery systems for all types of surgery, and endosurgery instruments for minimally invasive laparoscopic surgery. Patient Care products, including ECG electrodes for heart monitoring and pulse oximetry for blood oxygenation monitoring, are provided for various clinical settings.The company operates in two revenue segments: Orthopedic Surgery and General Surgery.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $73.740B 21.42
McKesson (MCK) United States $51.687B 15.01
AmerisourceBergen (ABC) United States $30.494B 13.47
West Pharmaceutical Services (WST) United States $25.090B 38.20
Laboratory Of America Holdings (LH) United States $24.019B 10.51
Cardinal Health (CAH) United States $17.095B 13.13
Cooper (COO) United States $16.392B 25.23
Invacare (IVC) United States $0.035B 0.00